SCIENCE IN THE NEWS DAILY
Synthetic Yeast to Brew Up Vital Malaria Drug
from New Scientist
A synthetic organism could be producing enough of a key malaria drug to treat the world within three years.
A species of yeast has been fitted with synthetic genes that make a compound called artemisinin, which is used to treat multi-drug resistant strains of malaria. The chemical is currently extracted from a Chinese wormwood shrub called Artemisia annua, but this is a relatively expensive process.
Jay Keasling, of the University of California, Berkeley, and colleagues announced 2 years ago that they had engineered artimisinic acid-producing yeast by inserting around 12 synthetic genes which had been copied from A. annua and several other species. They have now optimised the process and are scaling it up for industrial production in partnership with drugs giant Sanofi-Aventis.
Read more ...
Connect With Us:
PODCAST & VIDEO: 3D Printing Replacement Body Parts
Regenerative medicine, a fledgling field with the aim of regrowing parts from a person’s own cells, is being amplified with 3D-printing technology, which can now use organic materials to create scaffolds that cells need to grow into their final forms. Richard Wysk, a professor of industrial and systems engineering at North Carolina State University, discusses the latest successes with this research, and the timeline for creating more complicated structures.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.